InsiderTrades

Form 4 for CTKB Cytek Biosciences, Inc.

Accepted 2023-08-21 00:00:00 ET · period of report 2023-08-18 · accession 0001209191-23-046829 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-08-21 2023-08-18 CTKB Williams Paul Christopher COO M - OptEx — +920 1,294 +246% —
D 2023-08-21 2023-08-18 CTKB Williams Paul Christopher COO F - Tax $8.46 -359 935 -28% -$3,037
D 2023-08-21 2023-08-18 CTKB Williams Paul Christopher COO M - OptEx $0.00 -920 13.2K -7% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-08-18 M A 920 — 1,294 D — — (F1) Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
2 Common Common Stock 2023-08-18 F D 359 $8.46 935 D — — (F2) Represents the number of shares withheld by and surrendered to the Issuer on August 18, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award.
3 Derivative Restricted Stock Units 2023-08-18 M D 920 $0.00 13,193 D — · — to — 920 08/18/2023 (F1) Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock. (F3) The shares subject to the RSU Award shall vest over four years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2023 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2023 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2024 and each March 10 thereafter, until fully vested.